Live Breaking News & Updates on Neilr Cashman

(0)
TORONTO and CAMBRIDGE, Mass., May 12, 2021 (GLOBE NEWSWIRE) ProMIS Neurosciences, Inc. (TSX: PMN); (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics selectively targeting toxic oligomers implicated in the development of neurodegenerative diseases, today announced the appointment of Rudolph Tanzi, Ph.D, as Chair of the Company s scientific advisory board (SAB). Dr. Tanzi is the Joseph P. and Rose F. Kennedy Professor of Neurology at Harvard University and Vice-Chair of Neurology, Director of the Genetics and Aging Research Unit, and Co-Director of the Henry and Allison McCance Center for Brain Health at Massachusetts General Hospital. ....

New York , United States , Memorial Sloan Kettering Cancer Center , United Kingdom , Cold Spring Harbor Laboratory , San Diego , City Of , Rudy Tanzi , Florence Riford , C Warren Olanow , Sharon Cohen , Neilr Cashman , Eugene Williams , Nicholas Rigopulos , Neil Cashman , Williamc Mobley , Joe Perry , Andre Strydom , David Wishart , Michellel Hastings , Rudolph Tanzi , King College London , Department Of Neuroscience , Research Unit , University Of British Columbia , Royal Institute Of Technology ,